Systemic Treatment of Non-Small Cell Lung Cancer [electronic resource]

By:

Giaccone, Giuseppe

Publication details: Oxford University Press, USA, 2012.Description: 1 online resourceContent type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9780191502392 (electronic bk.)
0191502391 (electronic bk.)
1306260442 (electronic bk.)
9781306260442 (electronic bk.)

Subject(s):

Lungs -- Cancer -- Treatment

Online resources:

Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access

Summary: Lung cancer is the leading cause of cancer mortality worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85% of all cases of lung cancer. Most patients present with advanced disease and five-year survival is low at about 15%. Surgery is the main treatment for early stage disease. If patients are deemed inoperable, systemic chemotherapy is considered. For patients with locally advanced disease, multimodality therapy is administered where chemotherapy is given incombination with definitive radiation therapy or surgery in selected cases. Cytotoxic chemotherapy regimens mainly con

Holdings
Item type	Home library	Class number	URL	Status	Date due	Barcode
Electronic book	Stenhouse Library		Link to resource	Available

Description based on print version record.

Lung cancer is the leading cause of cancer mortality worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85% of all cases of lung cancer. Most patients present with advanced disease and five-year survival is low at about 15%. Surgery is the main treatment for early stage disease. If patients are deemed inoperable, systemic chemotherapy is considered. For patients with locally advanced disease, multimodality therapy is administered where chemotherapy is given incombination with definitive radiation therapy or surgery in selected cases. Cytotoxic chemotherapy regimens mainly con

There are no comments on this title.

to post a comment.